Interest in having HPV vaccination among adolescent boys in England

This publication has 43 references indexed in Scilit:

• Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old
  Clinical and Vaccine Immunology, 2012
• Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
  The Lancet Oncology, 2011
• HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
  New England Journal of Medicine, 2011
• The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme
  Sexually Transmitted Infections, 2011
• Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
  The Lancet, 2011
• Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
  New England Journal of Medicine, 2011
• Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
  The Lancet Infectious Diseases, 2011
• Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
  BMJ, 2010
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
  International Journal of Cancer, 2010
• Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
  BMJ, 2009